141 related articles for article (PubMed ID: 34085620)
1. Laboratory-identified vancomycin-resistant enterococci bacteremia incidence: A standardized infection ratio prediction model.
Tanwar SSS; Weiner-Lastinger LM; Bell JM; Allen-Bridson K; Bagchi S; Dudeck MA; Edwards JR
Infect Control Hosp Epidemiol; 2022 Jun; 43(6):714-718. PubMed ID: 34085620
[TBL] [Abstract][Full Text] [Related]
2. The impact of vancomycin-resistant
Cho SY; Kim HM; Chung DR; Choi JR; Lee MA; Huh HJ; Lee NY; Huh K; Kang CI; Peck KR
Infect Control Hosp Epidemiol; 2022 May; 43(5):603-608. PubMed ID: 33993892
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
Popiel KY; Miller MA
Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
[TBL] [Abstract][Full Text] [Related]
4. Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada.
Johnstone J; Chen C; Rosella L; Adomako K; Policarpio ME; Lam F; Prematunge C; Garber G;
Am J Infect Control; 2018 Nov; 46(11):1266-1271. PubMed ID: 29903421
[TBL] [Abstract][Full Text] [Related]
5. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
[TBL] [Abstract][Full Text] [Related]
6. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
[TBL] [Abstract][Full Text] [Related]
7. Impact of discontinuing isolation in a private room for patients infected or colonized with vancomycin-resistant enterococci (VRE) on the incidence of healthcare-associated VRE bacteraemia in a hospital with a predominantly shared-room setting.
Chang E; Im D; Lee HY; Lee M; Lee CM; Kang CK; Park WB; Kim NJ; Choe PG; Oh M
J Hosp Infect; 2023 Feb; 132():1-7. PubMed ID: 36473555
[TBL] [Abstract][Full Text] [Related]
8. Influence of an independent quarterly audit on publicly reported vancomycin-resistant enterocococi bacteremia data in Ontario, Canada.
Prematunge C; Policarpio ME; Johnstone J; Adomako K; Nadolny E; Lam F; Li Y; Brown KA; Garber G
Am J Infect Control; 2018 Sep; 46(9):1036-1040. PubMed ID: 29661626
[TBL] [Abstract][Full Text] [Related]
9. Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance system.
Dembek ZF; Kellerman SE; Ganley L; Capacchione CM; Tenover FC; Cartter ML; Van Kruiningen HJ; Jarvis WR; Hadler JL
Infect Control Hosp Epidemiol; 1999 Oct; 20(10):671-5. PubMed ID: 10530644
[TBL] [Abstract][Full Text] [Related]
10. High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey.
Vuichard-Gysin D; Sommerstein R; Kronenberg A; Buetti N; Eder M; Piezzi V; Gardiol C; Schlegel M; Harbarth S; Widmer A;
Antimicrob Resist Infect Control; 2022 Jan; 11(1):19. PubMed ID: 35090563
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin resistant enterococci healthcare associated infections.
Orsi GB; Ciorba V
Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
[TBL] [Abstract][Full Text] [Related]
12. Comparative Epidemiology of Vancomycin-Resistant Enterococci Colonization in an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term Care Facilities in Singapore.
Tan D; Htun HL; Koh J; Kanagasabai K; Lim JW; Hon PY; Ang B; Chow A
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224534
[TBL] [Abstract][Full Text] [Related]
13. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the National Healthcare Safety Network standardized infection ratio risk adjustment for healthcare-facility-onset
Polage CR; Quan KA; Madey K; Myers FE; Wightman DA; Krishna S; Grein JD; Gibbs L; Yokoe D; Mabalot SC; Chinn R; Hallmark A; Rubin Z; Fontenot M; Cohen S; Birnbaum D; Huang SS; Torriani FJ
Infect Control Hosp Epidemiol; 2020 Apr; 41(4):404-410. PubMed ID: 32052726
[TBL] [Abstract][Full Text] [Related]
15. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies.
Almyroudis NG; Osawa R; Samonis G; Wetzler M; Wang ES; McCarthy PL; Segal BH
Infect Control Hosp Epidemiol; 2016 Apr; 37(4):398-403. PubMed ID: 26750087
[TBL] [Abstract][Full Text] [Related]
17. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
[TBL] [Abstract][Full Text] [Related]
18. Modeling the regional spread and control of vancomycin-resistant enterococci.
Lee BY; Yilmaz SL; Wong KF; Bartsch SM; Eubank S; Song Y; Avery TR; Christie R; Brown ST; Epstein JM; Parker JI; Huang SS
Am J Infect Control; 2013 Aug; 41(8):668-73. PubMed ID: 23896284
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study.
Kaya A; Kaya SY; Balkan II; Bayramlar OF; Mete B; Saltoglu N; Aygün G; Tabak ÖF
Wien Klin Wochenschr; 2021 May; 133(9-10):478-483. PubMed ID: 32910333
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
Mac S; Fitzpatrick T; Johnstone J; Sander B
Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
